Edward Glazebrook
Nurse Practitioner · Worcester, MANPI 1447919535
Payments from drug & device makers
Across 211 payments — averaging $23.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$643
- Teva Pharmaceuticals USA, Inc.$583
- AbbVie$521
- Otsuka America Pharmaceutical, Inc.$339
- AstraZeneca$329
- Neurocrine Biosciences, Inc.$259
- plus $2K from 27 others
What the payments were for
- Food & beverage$4,980100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 25 | $643 |
| Teva Pharmaceuticals USA, Inc. | 20 | $583 |
| AbbVie | 24 | $521 |
| Otsuka America Pharmaceutical, Inc. | 17 | $339 |
| AstraZeneca | 13 | $329 |
| Neurocrine Biosciences, Inc. | 10 | $259 |
| Gilead | 9 | $243 |
| Exact Sciences | 8 | $193 |
| Aimmune Therapeutics, Inc. | 9 | $177 |
| Sumitomo Pharma America, Inc. | 7 | $161 |
| Lundbeck LLC | 7 | $150 |
| Ardelyx, Inc. | 6 | $138 |
| Biogen | 7 | $135 |
| Neurelis, Inc. | 3 | $115 |
| Verona Pharma, Inc. | 4 | $107 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $107 |
| Pfizer | 6 | $99 |
| Bayer | 4 | $91 |
| Amgen | 3 | $77 |
| Corcept Therapeutics | 3 | $73 |
| Novartis | 3 | $60 |
| Johnson & Johnson | 2 | $59 |
| Medtronic | 2 | $48 |
| GSK | 2 | $46 |
| Boehringer Ingelheim | 2 | $45 |
| Philips North America LLC | 2 | $40 |
| Abiomed | 1 | $27 |
| Qiagen, LLC | 1 | $23 |
| Inspire Medical Systems, Inc. | 1 | $22 |
| Sanofi Pasteur Inc. | 1 | $21 |
| Viatris Specialty LLC | 1 | $18 |
| Inogen, Inc. | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $15 |
How this compares
$4,980 in reported general payments places this provider in the 95th percentile of 3,855 nurse practitioner providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lisinopril | 21 | $188 |
| Atorvastatin Calcium | 22 | $181 |
| Gabapentin | 15 | $168 |
| Amlodipine Besylate | 20 | $135 |
| Oxycodone Hcl | 12 | $89 |
| Clonazepam | 11 | $82 |
| Warfarin Sodium | 12 | $72 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Worcester
- Amberly ChaplinWorcester$56K
- Ashley SchaeferWorcester$10K
- Louisa AsiamahWorcester$7K
- Alison McManusBoston$346K
- Lauri WelchNorth Chelmsford$110K
- Teresa FogarenBoston$102K
- Carolyn MetivierBoston$93K
- Deborah GearySalem$80K
- Darlene MadoreBrockton$42K
- Nancy SydowN Chelmsford$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.